Editor’s note: This is an updated version of an article first published Aug. 22, 2013. At StreetAuthority, we often look at where Washington’s most powerful men are putting their money. Recently, we learned what not to do from Barack Obama’s portfolio, picked up some tips on diversification from Mitt Romney… Read More
Analyst Articles
Forget Bernanke, Invest Alongside His Likely Successor
Editor’s note: This is an updated version of an article first published Aug. 22, 2013. At StreetAuthority, we often look at where Washington’s most powerful men are putting their money. Recently, we learned what not to do from Barack Obama’s portfolio, picked up some tips on diversification from Mitt Romney and revealed Ron Paul’s affinity for gold and silver miners. But none of these men have the potential clout of a woman who may soon become the world’s most powerful economic force. If you’re thinking of Hillary Clinton, Marissa Mayer or Angela Merkel, you’re wrong. As the first chairwoman of… Read More
Editor’s note: This is an updated version of an article first published Aug. 22, 2013. At StreetAuthority, we often look at where Washington’s most powerful men are putting their money. Recently, we learned what not to do from Barack Obama’s portfolio, picked up some tips on diversification from Mitt Romney and revealed Ron Paul’s affinity for gold and silver miners. But none of these men have the potential clout of a woman who may soon become the world’s most powerful economic force. If you’re thinking of Hillary Clinton, Marissa Mayer or Angela Merkel, you’re wrong. As the first chairwoman of the Federal Reserve, Janet Yellen would have a deciding role in determining the monetary policy of the world’s largest economy and her portfolio holds some interesting stocks. I know, Yellen has yet to be approved by Congress, but she has some important qualifications:#-ad_banner-# First, Yellen has been on the Fed’s Board of Governors for a full economic cycle, and she’s been there for the discussions on an unprecedented monetary policy. Obama needs that kind of institutional knowledge to help guide policy coming out of this historic period. Second, Yellen is much more dovish than any other possible pick, helping to… Read More
Orphan drugs, those treating rare conditions for small segments of the population, do not normally get much attention compared with the likes of a $12.9 billion Lipitor — but their approval by regulators can still mean huge gains at small biopharmaceutical companies. One company in particular has… Read More
2 Gold Stocks Even Better Than Gold Itself
Sometimes I feel as if I have the best job in the world, especially each time the calendar turns. You see, this is when most of the fruits of the team’s labors come together here at StreetAuthority. It’s when we publish many of the newsletters we’ve been… Read More
If you were asked what the scarcest commodity on the planet was, I am sure many of you would say gold or oil. But it’s neither of these, nor is it platinum or copper or one of the rare earth metals. And I know many people will say fresh water,… Read More
4 Ways To Profit From Big Data
The business of data is growing bigger and bigger. An astounding 2.5 quintillion bytes of data are created every day, cluttering computer systems around the globe. As more and more companies clamor to find space for the new, archive the old, and analyze it all so it… Read More
A forest fire is extremely destructive in the short run. But in the long run, the few trees left standing are sitting pretty. Not only do they have a monopoly on the sun, they also have all the room they need to grow to new heights. That’s… Read More
4 Stocks Insiders Are Buying… And Why You Should Care
I’ve been tracking the moves made by insiders for more than two decades — but recently, I’ve been paying less attention. That’s because my experience has shown that following the moves of insiders in a rising stock market isn’t fully helpful, as a rising tide lifts all boats anyway, and… Read More
This Week, Watch Earnings, Not Washington…
Stocks ended the week unchanged, but they should break out soon as earnings season begins.#-ad_banner-# Traders Seem Unconcerned By Washington SPDR S&P 500 (NYSE: SPY) closed down $0.02 on the week, virtually unchanged from a week ago. Despite the small change in price, analysts were very active, explaining that… Read More
The High-Yield Stocks Nobody Is Talking About
For any of you who have read Sir Arthur Conan Doyle’s “Sherlock Holmes” stories, you know the famous detective uses the power of observation, deductive reasoning, and extensive research to solve complex mysteries. But the fictional detective also occasionally relied on a group of street children that the public mostly… Read More